Medical cannabis supply-chain services
The stated scope includes pharmaceutical supply, licensed import, GMP-compliant processing and quality management.
Source: LinkedIn company description · Retrieved October 13, 2026
Canna Capital Group builds integrated cannabis healthcare infrastructure for the regulated European market.
The group connects stages of the medical cannabis value chain, including pharmaceutical supply, licensed import, GMP-compliant processing, quality management, B2B distribution, telemedicine and patient care. The group describes its platform as structured and emphasizes Swiss quality standards, regulatory expertise and a partner network.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The stated scope includes pharmaceutical supply, licensed import, GMP-compliant processing and quality management.
Source: LinkedIn company description · Retrieved October 13, 2026
The group connects B2B distribution, telemedicine and patient care within its value chain.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.